Beijing Scitop Bio Tech Co Ltd (300858) — Cash Flow-to-Debt Ratio
Beijing Scitop Bio Tech Co Ltd (300858) has a Cash Flow-to-Debt Ratio of 0.39x as of September 2025, meaning its operating cash flow of CN¥44.72 Million could theoretically repay 0% of its total liabilities (CN¥114.58 Million) in one year. See 300858 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Beijing Scitop Bio Tech Co Ltd Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Beijing Scitop Bio Tech Co Ltd across 11 annual periods. Also explore 300858 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Beijing Scitop Bio Tech Co Ltd (2015–2025)
Year-by-year debt coverage analysis for Beijing Scitop Bio Tech Co Ltd. For market capitalisation and broader financial context, see Beijing Scitop Bio Tech Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | CN¥123.44 Million | CN¥176.08 Million | ▼ -37.8% |
| 2024 | 1.13x | CN¥142.11 Million | CN¥126.03 Million | ▼ -19.0% |
| 2023 | 1.39x | CN¥107.27 Million | CN¥77.10 Million | ▼ -11.9% |
| 2022 | 1.58x | CN¥148.46 Million | CN¥93.99 Million | ▲ +5.0% |
| 2021 | 1.50x | CN¥110.27 Million | CN¥73.33 Million | ▲ +50.3% |
| 2020 | 1.00x | CN¥66.67 Million | CN¥66.66 Million | ▼ -32.7% |
| 2019 | 1.49x | CN¥98.27 Million | CN¥66.14 Million | ▲ +19.3% |
| 2018 | 1.25x | CN¥89.55 Million | CN¥71.91 Million | ▼ -16.5% |
| 2017 | 1.49x | CN¥84.00 Million | CN¥56.30 Million | ▲ +226.8% |
| 2016 | 0.46x | CN¥32.73 Million | CN¥71.69 Million | ▲ +2142.4% |
| 2015 | 0.02x | CN¥2.69 Million | CN¥131.89 Million | — |